Clinical Trial Update: The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of CC-10004 in chronic cutaneous sarcoidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Sarcoidosis
• Sarcoidosis

Drugs mentioned

• CC-10004

Snippet

Sponsor: University of Cincinnati | Conditions: Sarcoidosis, Cutaneous Sarcoidosis | Phase 2, Phase 3 | Status: COMPLETED